BlackRock Inc. - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 29 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2017$55,000
-30.4%
94,2030.0%0.00%
Q2 2017$79,000
-43.2%
94,203
-7.9%
0.00%
Q1 2017$139,000
-77.0%
102,302
-69.9%
0.00%
-100.0%
Q1 2015$604,000
-3.4%
339,5550.0%0.00%0.0%
Q4 2014$625,000
-24.0%
339,5550.0%0.00%0.0%
Q3 2014$822,000
-38.7%
339,555
-7.5%
0.00%
-50.0%
Q2 2014$1,340,000
-20.3%
367,0550.0%0.00%
-33.3%
Q1 2014$1,681,000
+17.7%
367,0550.0%0.00%
+50.0%
Q4 2013$1,428,000367,0550.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,825,000$1,206,0000.39%
Zhang Financial LLC 45,000$33,0000.02%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 472,553$313,0000.01%
MEITAV INVESTMENT HOUSE LTD 127,062$85,0000.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 324,479$215,000,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$200,0000.00%
Renaissance Technologies 1,993,500$1,318,0000.00%
WEDBUSH SECURITIES INC 15,000$10,0000.00%
TWO SIGMA SECURITIES, LLC 57,127$38,0000.00%
Psagot Value Holdings Ltd. 29,193$20,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders